IEQ Capital’s Halozyme HALO Stock Holding History

IEQ Capital’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-29,549	Closed	-$1.99M	–	1975
2025 Q4	$1.99M	Sell	29,549 -19,974	-40%	-$1.34M	0.01%	792
2025 Q3	$3.63M	Buy	+49,523	New	+$3.29M	0.01%	573

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

IEQ Capital's HALO Position: Q1 2026 in Review

IEQ Capital sold out of Halozyme (HALO) in Q1 2026, closing a stake of 29,549 shares — an estimated $1.99M sold.

IEQ Capital first reported a position in HALO in Q3 2025 and held it in 2 quarters. The position peaked at $3.63M in Q3 2025. 636 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

IEQ Capital reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
IEQ Capital sold 29,549 Halozyme shares in Q1 2026, an estimated $1.99M.
IEQ Capital first reported a position in Halozyme in Q3 2025 and held it in 2 quarters.
IEQ Capital's Halozyme position peaked at $3.63M in Q3 2025.
636 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.